ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,209.70
0.22%
S&P ASX All Technology
3,762.90
0.43%
Brent Oil
80.015
-0.33%
US Dollar vs AUD
1.61719
0.12%
Bitcoin
94,920.04
0.44%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Bio Techne Corporation (TECH) Share Price

Bio Techne Corporation

Bio Techne Corporation (TECH)

TechFinancials Inc
Global X Management AUS Ltd
Evolve Fangma Index ETF
76.42
3.11
(4.24%)
Closed 14 January 8:00AM
Delayed by 15 minutes
76.75
0.33
(0.43%)
After Hours: 11:24AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
76.75
Bid
76.50
Offer
76.90
Volume
1,356,631
72.5222 Day's Range 76.48
61.16 52 Week Range 85.57
Market Cap
12.195B
Previous Close
73.31
Open
73.03
Last Trade
400
@
76.75
(formt)
Last Trade Time
Financial Volume
US$ 102,168,602
VWAP
75.3105
Average Volume (3m)
885,133
Shares Outstanding
158,891,800
Dividend Yield
0.42%
PE Ratio
72.26
Earnings Per Share (EPS)
1.06
Revenue
1.16B
Net Profit
168.11M

About Bio Techne Corporation

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.bio-techne.com
Headquarters
Minneapolis, Minnesota, USA
Founded
-
Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TECH. The last closing price for Bio Techne was US$73.31. Over the last year, Bio Techne shares have traded in a share price range of US$ 61.16 to US$ 85.57.

Bio Techne currently has 158,891,800 shares in issue. The market capitalisation of Bio Techne is US$11.65 billion. Bio Techne has a price to earnings ratio (PE ratio) of 72.26.

Ask ADVFN Intelligence (AI)

TECH Latest News

More News

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire MINNEAPOLIS, Jan. 10, 2025 MINNEAPOLIS, Jan. 10, 2025...

10 January 2025
PR Newswire (US)

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire ST. PAUL, Minn., Jan. 8, 2025 ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in...

08 January 2025
PR Newswire (US)

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire MINNEAPOLIS, Jan. 7, 2025 MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...

07 January 2025
PR Newswire (US)

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...

20 December 2024
PR Newswire (US)

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...

19 December 2024
PR Newswire (US)

ScaleReady awards a G-Rex® Grant to Moonlight Bio

ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...

18 December 2024
PR Newswire (US)

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...

12 December 2024
PR Newswire (US)

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY PR Newswire MINNEAPOLIS, Dec. 10, 2024 Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium MINNEAPOLIS, Dec. 10...

10 December 2024
PR Newswire (US)

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Nov. 27, 2024 MINNEAPOLIS, Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...

27 November 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.943.9832001083973.8176.7573.0767814774.15551646CS
41.2851.7027761213875.46577.6269.4868217473.21931397CS
125.978.4345860412570.7879.8665.6188513372.85663928CS
26-0.45-0.58290155440477.283.6265.6187225574.20811095CS
525.67.8706957132871.1585.5761.1698319873.22627466CS
156-30.1375-28.1955326862106.8875113.80551.7977958475.8398914CS
26022.7342.077008515454.02135.962538.792555300878.03089957CS

TECH - Frequently Asked Questions (FAQ)

What is the current Bio Techne share price?
The current share price of Bio Techne is US$ 76.75
How many Bio Techne shares are in issue?
Bio Techne has 158,891,800 shares in issue
What is the market cap of Bio Techne?
The market capitalisation of Bio Techne is USD 11.65B
What is the 1 year trading range for Bio Techne share price?
Bio Techne has traded in the range of US$ 61.16 to US$ 85.57 during the past year
What is the PE ratio of Bio Techne?
The price to earnings ratio of Bio Techne is 72.26
What is the cash to sales ratio of Bio Techne?
The cash to sales ratio of Bio Techne is 10.48
What is the reporting currency for Bio Techne?
Bio Techne reports financial results in USD
What is the latest annual turnover for Bio Techne?
The latest annual turnover of Bio Techne is USD 1.16B
What is the latest annual profit for Bio Techne?
The latest annual profit of Bio Techne is USD 168.11M
What is the registered address of Bio Techne?
The registered address for Bio Techne is 614 MCKINLEY PLACE N.E, MINNEAPOLIS, MINNESOTA, 55413
What is the Bio Techne website address?
The website address for Bio Techne is www.bio-techne.com
Which industry sector does Bio Techne operate in?
Bio Techne operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PHIOPhio Pharmaceuticals Corporation
US$ 6.50
(284.62%)
281.98M
SLRXSalarius Pharmaceuticals Inc
US$ 3.65
(133.23%)
120.26M
VRMEVerifyMe Inc
US$ 4.1575
(63.04%)
57.6M
ATPCAgape ATP Corporation
US$ 1.9645
(55.91%)
84.16M
AVGRAvinger Inc
US$ 0.8248
(46.47%)
9.78M
EHGOEshallgo Inc
US$ 1.2408
(-62.06%)
6.74M
CMTLComtech Telecommunications Corporation
US$ 2.3491
(-43.12%)
4.37M
SVMHSRIVARU Holding Ltd
US$ 0.0352
(-43.04%)
184.27M
LAESSEALSQ Corporation
US$ 3.35
(-41.54%)
89.92M
NMHINatures Miracle Holding Inc
US$ 1.12
(-38.80%)
735.08k
GCTKGlucoTrack Inc
US$ 0.1493
(27.61%)
685.02M
PHIOPhio Pharmaceuticals Corporation
US$ 6.50
(284.62%)
281.98M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0627
(-28.83%)
232.25M
NVDANVIDIA Corporation
US$ 133.23
(-1.97%)
204.68M
RGTIRigetti Computing Inc
US$ 6.0344
(-32.43%)
192.21M

TECH Discussion

View Posts
Monksdream Monksdream 3 months ago
TECH under $75
👍️0
Monksdream Monksdream 4 months ago
TECH range bound
👍️0
Monksdream Monksdream 6 months ago
TECH under $100
👍️0
LordTurkeyBaster LordTurkeyBaster 3 years ago
Top Meme Stock Mentions Money to Move 01/03/2022

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 years ago
Top Meme Stock Mentions Money to Move 10/15/2021

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 years ago
Top Meme Stock Mentions Money to Move 10/14/2021

$TECH: $1B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
TREND1 TREND1 10 years ago
NO REASON.
👍️0
getarealjob getarealjob 10 years ago
No worries, just read a blurb on a new diet drug that sounds pretty promising from these guys. Fexaramine, from these guys, looking at clinicals in 2-3 years.

Is there a reason you're no longer following it or just got tired and needed more time with others?
👍️0
TREND1 TREND1 10 years ago
NO longer follow TECH.
SORRY
👍️0
getarealjob getarealjob 10 years ago
Hey Trend, saw you over on AAL. This guy just popped up on my radar, obviously nothing going on in the board. What are your thoughts on this, if you have any beyond your charts? Not sure if you're on this one or not.
👍️0
TREND1 TREND1 10 years ago
TECH D
👍️0

Your Recent History

NASDAQ
TECH
Bio Techne
AQEU
CTH1VH
Componenta Oyj
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads